hero section gradient
15 handpicked stocks

Planetary Resilience Portfolio

Companies building the critical infrastructure and technologies our world needs to adapt to increasing climate volatility. These stocks represent leaders in climate resilience solutions, carefully selected by professional analysts for their focus on protecting communities and essential systems.

Author avatar

Han Tan | Market Analyst

Published on June 18

Your Basket's Financial Footprint

Summary of total market capitalisation and cap breakdown for investor interpretation.

Key Takeaways for Investors
  • Large-cap dominance generally implies lower volatility and closer tracking to broad-market performance.
  • Suitable as a core holding to provide stable exposure rather than speculative, concentrated beta.
  • Expect steady, long-term appreciation rather than short-term explosive gains.
Total Market Cap
  • HASI: $3.52B

  • PL: $3.98B

  • GWRS: $288.19M

  • Other

About This Group of Stocks

1

Our Expert Thinking

As climate change intensifies, demand for adaptation solutions becomes non-negotiable. This collection focuses on companies creating the technologies and infrastructure that help communities withstand environmental shocks - from advanced monitoring systems to sustainable water management and reinforced physical structures.

2

What You Need to Know

This portfolio spans diverse sectors but shares a common purpose: enabling society to function despite climate volatility. These companies are positioned to benefit from increasing public and private investment in climate resilience, creating potential for sustained growth as adaptation becomes essential worldwide.

3

Why These Stocks

Each company was selected because its core business directly supports climate adaptation. The curation prioritizes leaders in resilient construction, resource sustainability, and environmental monitoring who are already seeing increased demand for their solutions due to recent surges in infrastructure funding.

Why You'll Want to Watch These Stocks

🌊

Rising From Necessity

Unlike optional innovations, climate resilience is becoming mandatory worldwide. These companies provide solutions that communities and businesses simply cannot function without as extreme weather intensifies.

💰

Following The Money Flow

Governments and corporations are directing unprecedented funding toward climate adaptation infrastructure. This financial wave is already boosting demand for the specialized solutions these companies provide.

🔮

Tomorrow's Essential Providers

As environmental volatility increases, these companies are positioned to become as fundamental to our society as utilities. Their services transition from "nice-to-have" to "can't-live-without" with each climate event.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions